Kythera Biopharmaceuticals' Series D Round

Kythera Biopharmaceuticals raised a round of funding on September 15, 2011.

Kythera (NASDAQ: KYTH) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. The C…

Articles about Kythera Biopharmaceuticals' Series D Round: